Anterior Cingulate Cortex Glutamatergic Metabolites and Mood Stabilizers in Euthymic Bipolar I Disorder Patients: A Proton Magnetic Resonance Spectroscopy Study

Goodwin, 2007 Sigitova, 2017, Biological hypotheses and biomarkers of bipolar disorder, Psychiatry Clin Neurosci, 71, 77, 10.1111/pcn.12476 Machado-Vieira, 2009, Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders, Curr Pharm Des, 15, 1595, 10.2174/138161209788168010 Manji, 2008, Bcl-2: A key regulator of affective resilience in the pathophysiology and treatment of severe mood disorders, Biol Psychiatry, 63, 243S Yüksel, 2010, Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders, Biol Psychiatry, 68, 785, 10.1016/j.biopsych.2010.06.016 Gigante, 2012, Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: A meta-analysis, Bipolar Disord, 14, 478, 10.1111/j.1399-5618.2012.01033.x Krystal, 2002, Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments, Mol Psychiatry, 7, S71, 10.1038/sj.mp.4001021 Diazgranados, 2010, A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression, Arch Gen Psychiatry, 67, 793, 10.1001/archgenpsychiatry.2010.90 Zarate, 2013, A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression, Biol Psychiatry, 74, 257, 10.1016/j.biopsych.2012.10.019 Park, 2015, Novel glutamatergic treatments for severe mood disorders, Curr Behav Neurosci Rep, 2, 198, 10.1007/s40473-015-0050-5 Keener, 2007, Neuroimaging in bipolar disorder: A critical review of current findings, Curr Psychiatry Rep, 9, 512, 10.1007/s11920-007-0070-2 Phillips, 2014, A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research, Am J Psychiatry, 171, 829, 10.1176/appi.ajp.2014.13081008 Govindaraju, 2000, Proton NMR chemical shifts and coupling constants for brain metabolites, NMR Biomed, 13, 129, 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V Kim, 1982, Increased serum glutamate in depressed patients, Arch Psychiatr Nervenkr, 232, 299, 10.1007/BF00345492 Altamura, 1993, Plasma and platelet excitatory amino acids in psychiatric disorders, Am J Psychiatry, 150, 1731, 10.1176/ajp.150.11.1731 Mauri, 1998, Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment, Neuropsychobiology, 37, 124, 10.1159/000026491 Mitani, 2006, Correlation between plasma levels of glutamate, alanine and serine with severity of depression, Prog Neuropsychopharmacol Biol Psychiatry, 30, 1155, 10.1016/j.pnpbp.2006.03.036 Levine, 2000, Increased cerebrospinal fluid glutamine levels in depressed patients, Biol Psychiatry, 47, 586, 10.1016/S0006-3223(99)00284-X Frye, 2007, Low cerebrospinal fluid glutamate and glycine in refractory affective disorder, Biol Psychiatry, 61, 162, 10.1016/j.biopsych.2006.01.024 Francis, 1989, Brain amino acid concentrations and Ca2+-dependent release in intractable depression assessed antemortem, Brain Res, 494, 315, 10.1016/0006-8993(89)90600-8 Eastwood, 2010, Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder, Biol Psychiatry, 67, 1010, 10.1016/j.biopsych.2009.12.004 Scarr, 2003, Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder, Bipolar Disord, 5, 257, 10.1034/j.1399-5618.2003.00024.x Beneyto, 2007, Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders, Neuropsychopharmacology, 32, 1888, 10.1038/sj.npp.1301312 Beneyto, 2008, Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder, Neuropsychopharmacology, 33, 2175, 10.1038/sj.npp.1301604 Hashimoto, 2002, Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: Involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation, J Neurochem, 80, 589, 10.1046/j.0022-3042.2001.00728.x Kumar, 2010, Cell death mechanisms in the early stages of acute glutamate neurotoxicity, Neurosci Res, 66, 271, 10.1016/j.neures.2009.11.009 Gigante, 2011, Morphometric post-mortem studies in bipolar disorder: Possible association with oxidative stress and apoptosis, Int J Neuropsychopharmacol, 14, 1075, 10.1017/S146114571000146X Soeiro-de-Souza, 2012, Translating neurotrophic and cellular plasticity: From pathophysiology to improved therapeutics for bipolar disorder, Acta Psychiatr Scand, 126, 332, 10.1111/j.1600-0447.2012.01889.x Zung, 2016, The influence of lithium on hippocampal volume in elderly bipolar patients: A study using voxel-based morphometry, Transl Psychiatry, 6, e846, 10.1038/tp.2016.97 Colla, 2009, Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol, Mol Psychiatry, 14, 696, 10.1038/mp.2008.26 Bhagwagar, 2007, Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects, Biol Psychiatry, 61, 806, 10.1016/j.biopsych.2006.08.048 Senaratne, 2009, Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: A proton magnetic resonance spectroscopy study, Psychiatry Res, 172, 205, 10.1016/j.pscychresns.2008.07.007 Drevets, 2000, Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression, Prog Brain Res, 126, 413, 10.1016/S0079-6123(00)26027-5 Phillips, 2003, Neurobiology of emotion perception I: The neural basis of normal emotion perception, Biol Psychiatry, 54, 504, 10.1016/S0006-3223(03)00168-9 Kaufman, 2009, Brain GABA levels in patients with bipolar disorder, Prog Neuropsychopharmacol Biol Psychiatry, 33, 427, 10.1016/j.pnpbp.2008.12.025 Anticevic, 2015, Ventral anterior cingulate connectivity distinguished nonpsychotic bipolar illness from psychotic bipolar disorder and schizophrenia, Schizophr Bull, 41, 133, 10.1093/schbul/sbu051 Liu, 2012, Trait and state corticostriatal dysfunction in bipolar disorder during emotional face processing, Bipolar Disord, 14, 432, 10.1111/j.1399-5618.2012.01018.x Foland-Ross, 2011, Investigation of cortical thickness abnormalities in lithium-free adults with bipolar I disorder using cortical pattern matching, Am J Psychiatry, 168, 530, 10.1176/appi.ajp.2010.10060896 Soeiro-de-Souza, 2013, Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder, Neuropsychopharmacology, 38, 468, 10.1038/npp.2012.203 Ehrlich, 2015, Alterations of cerebral glutamate in the euthymic state of patients with bipolar disorder, Psychiatry Res, 233, 73, 10.1016/j.pscychresns.2015.05.010 Soeiro-de-Souza, 2015, Anterior cingulate glutamate-glutamine cycle metabolites are altered in euthymic bipolar I disorder, Eur Neuropsychopharmacol, 25, 2221, 10.1016/j.euroneuro.2015.09.020 Kubo, 2017, 1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder, J Affect Disord, 208, 139, 10.1016/j.jad.2016.08.046 Machado-Vieira, 2015, A longitudinal (6-week) 3T (1)H-MRS study on the effects of lithium treatment on anterior cingulate cortex metabolites in bipolar depression, Eur Neuropsychopharmacol, 25, 2311, 10.1016/j.euroneuro.2015.08.023 First, 1996 American Psychiatric Association, 2000 Young, 1978, A rating scale for mania: Reliability, validity and sensitivity, Br J Psychiatry, 133, 429, 10.1192/bjp.133.5.429 Hamilton, 1967, Development of a rating scale for primary depressive illness, Br J Soc Clin Psychol, 6, 278, 10.1111/j.2044-8260.1967.tb00530.x Schubert, 2004, Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla, Neuroimage, 21, 1762, 10.1016/j.neuroimage.2003.11.014 Provencher, 1993, Estimation of metabolite concentrations from localized in vivo proton NMR spectra, Magn Reson Med, 30, 672, 10.1002/mrm.1910300604 Kreis, 2004, Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts, NMR Biomed, 17, 361, 10.1002/nbm.891 Gasparovic, 2006, Use of tissue water as a concentration reference for proton spectroscopic imaging, Magn Reson Med, 55, 1219, 10.1002/mrm.20901 Ongur, 2008, Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania, Biol Psychiatry, 64, 718, 10.1016/j.biopsych.2008.05.014 Michael, 2003, Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex, Psychopharmacology (Berl), 168, 344, 10.1007/s00213-003-1440-z Frye, 2007, Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression, Neuropsychopharmacology, 32, 2490, 10.1038/sj.npp.1301387 Dager, 2004, Brain metabolic alterations in medication-free patients with bipolar disorder, Arch Gen Psychiatry, 61, 450, 10.1001/archpsyc.61.5.450 Hajek, 2008, A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy, J Psychiatry Neurosci, 33, 531 Garcia, 2009, Valproate-induced metabolic changes in patients with epilepsy: Assessment with H-MRS, Epilepsia, 50, 486, 10.1111/j.1528-1167.2008.01801.x Friedman, 2014, Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder, Biol Psychiatry, 56, 340, 10.1016/j.biopsych.2004.06.012